Evidence map›Paper›PMID 26289816›Full record

ArticleMalaria journal2015

Inhibition by stabilization: targeting the Plasmodium falciparum aldolase-TRAP complex.

Sondra Maureen Nemetski, Timothy J Cardozo, Gundula Bosch, Ryan Weltzer, Kevin O'Malley, Ijeoma Ejigiri, Kota Arun Kumar, Carlos A Buscaglia, Victor Nussenzweig, Photini Sinnis and 2 more

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 27 citations in OpenAlex.

  1. Induced proximity-based therapeutic modalities.Nature reviews. Drug discovery · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Molecular Glue Discovery: Current and Future Approaches.Journal of medicinal chemistry · 2023
    Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 4 countries.

Sondra Maureen NemetskiDepartment of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, USA. maureen.nemetski@gmail.com.
Timothy J CardozoDepartment of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, USA. Timothy.Cardozo@nyumc.org.
Gundula BoschDepartment of Molecular Microbiology and Immunology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, USA. gbosch@jhu.edu.
Ryan WeltzerDepartment of Biochemistry and Molecular Biology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, USA. ryan.weltzer@gmail.com.
Kevin O'MalleyDepartment of Biochemistry and Molecular Biology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, USA. kevinomalley87@gmail.com.
Ijeoma EjigiriDepartment of Medical Parasitology, New York University School of Medicine, New York, USA. ijeoma_ejigiri@yahoo.com.
Kota Arun KumarMichael Heidelberg Division of Pathology of Infectious Diseases, Department of Pathology, New York University School of Medicine, New York, USA. kumar_arun03@yahoo.com.
Carlos A BuscagliaInstituto de Investigaciones Biotecnológicas-Instituto Tecnológico de Chascomús (IIB-INTECH), Universidad Nacional de General San Martín-CONICET, 1650, San Martín, Buenos Aires, Argentina. cbuscaglia89@gmail.com.
Victor NussenzweigMichael Heidelberg Division of Pathology of Infectious Diseases, Department of Pathology, New York University School of Medicine, New York, USA. Victor.Nussenzweig@nyumc.org.
Photini SinnisDepartment of Molecular Microbiology and Immunology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, USA. psinnis1@jhu.edu.
Jelena LevitskayaDepartment of Molecular Microbiology and Immunology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, USA. lelena1@jhu.edu.
Jürgen BoschDepartment of Biochemistry and Molecular Biology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, USA. jbosch@jhu.edu.
Johns Hopkins University · USNew York University · USConsejo Nacional de Investigaciones Científicas y Técnicas · ARNewYork–Presbyterian Hospital · USUniversity of Hyderabad · INYahoo (Spain) · ES

Funding

Structure and Function of the Circumsporozoite ProteinR01AI056840 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SINNIS, PHOTINI · 2005 to 2014
$3.8M
Chemical Biology Design For MalariaDP2OD004631 · OD · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CARDOZO, TIMOTHY J · 2008 to 2014
$3.1M
Computational & Biochemical Studies of the Malarial Blood Stage Invasion ComplexF30HL094052 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI NEMETSKI, SONDRA MAUREEN · 2008 to 2010
$90k
NHLBI NIH HHS F30 HL094052NHLBI NIH HHS F30HL094052NIAID NIH HHS 5R01AI056840NIAID NIH HHS R01 AI056840NIH HHS DP2 OD004631
6 · The paper itself

Abstract

backgroundEmerging resistance of the malaria parasite Plasmodium to current therapies underscores the critical importance of exploring novel strategies for disease eradication. Plasmodium species are obligate intracellular protozoan parasites. They rely on an unusual form of substrate-dependent motility for their migration on and across host-cell membranes and for host cell invasion. This peculiar motility mechanism is driven by the 'glideosome', an actin-myosin associated, macromolecular complex anchored to the inner membrane complex of the parasite. Myosin A, actin, aldolase, and thrombospondin-related anonymous protein (TRAP) constitute the molecular core of the glideosome in the sporozoite, the mosquito stage that brings the infection into mammals.

methodsVirtual library screening of a large compound library against the PfAldolase-TRAP complex was used to identify candidate compounds that stabilize and prevent the disassembly of the glideosome. The mechanism of these compounds was confirmed by biochemical, biophysical and parasitological methods.

resultsA novel inhibitory effect on the parasite was achieved by stabilizing a protein-protein interaction within the glideosome components. Compound 24 disrupts the gliding and invasive capabilities of Plasmodium parasites in in vitro parasite assays. A high-resolution, ternary X-ray crystal structure of PfAldolase-TRAP in complex with compound 24 confirms the mode of interaction and serves as a platform for future ligand optimization.

conclusionThis proof-of-concept study presents a novel approach to anti-malarial drug discovery and design. By strengthening a protein-protein interaction within the parasite, an avenue towards inhibiting a previously "undruggable" target is revealed and the motility motor responsible for successful invasion of host cells is rendered inactive. This study provides new insights into the malaria parasite cell invasion machinery and convincingly demonstrates that liver cell invasion is dramatically reduced by 95 % in the presence of the small molecule stabilizer compound 24.

Indexed as

AnimalsCell LineCell SurvivalCrystallography, X-RayFructose-Bisphosphate AldolaseHepatocytesHumansMembrane ProteinsMolecular Docking SimulationMultiprotein ComplexesPlasmodium falciparumProtein StabilityProtozoan ProteinsRabbitsSmall Molecule LibrariesSurface Plasmon ResonanceFructose-Bisphosphate AldolaseMembrane ProteinsMultiprotein ComplexesProtozoan ProteinsSmall Molecule Librariesthrombospondin-related adhesive protein, protozoan

Identifiers

PMID26289816
PMCPMC4545932
OpenAlexW2155960437

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.